Harbinger Health
Blood-based multi-cancer early detection tests using biomarkers
- Sector
- Medtech
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 37 pending · first 2026
Capital timeline
No federal awards or Form D filings are on record for this company.
Many early companies raise without filing a Form D, or have not yet won a federal award. New records appear here as the sources update.
Checked: SEC EDGAR Form D through Oct 23, 2026; SBIR and STTR awards through Oct 21, 2026; USAspending contract awards
Founder? Add funding contextStanding in Medtech · 4531 companies
Line = median- Federal contractsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 1 granted of 38- PendingPrioritization Of Healthcare Resources In Cancer CareUSPTOApplication 19573525
- PendingTiered Testing For High Risk PopulationsUSPTOApplication 19339016
- GrantedNucleic Acid Enrichment MethodUSPTOUS 12,522,865
Show all 38 patent records
- Prioritization Of Healthcare Resources In Cancer CareSep 3, 2026 · Application 19573525Pending
- Tiered Testing For High Risk PopulationsJan 15, 2026 · Application 19339016Pending
- Nucleic Acid Enrichment MethodJan 13, 2026 · US 12,522,865Granted
- Probe Blockers For Enrichment Of Target Nucleic Acid SequencesJul 10, 2025 · Application 19009650Pending
- Tiered Testing For High Risk PopulationsJul 10, 2025 · Application 19009609Pending
- Bodily Fluid Target EnrichmentOct 3, 2024 · Application 18385649Pending
- Targeted Rare Allele Crispr EnrichmentSep 19, 2024 · Application 18524829Pending
- Rare Nucleic Acid DetectionSep 19, 2024 · Application 18514333Pending
- Solid Phase Negative EnrichmentSep 19, 2024 · Application 18519589Pending
- Solid Phase Negative EnrichmentJun 27, 2024 · Application 18131634Pending
- Rare Nucleic Acid DetectionJun 27, 2024 · Application 18128698Pending
- Bodily Fluid Target EnrichmentJun 20, 2024 · Application 18121328Pending
- Selective EnrichmentMay 23, 2024 · Application 18212371Pending
- Selective Protection Of Nucleic AcidsFeb 15, 2024 · Application 18124212Pending
- Isolation Of Target Nucleic AcidsMar 3, 2022 · Application 17498290Pending
- Methods For Depleting Unmethylated Nucleic Acid MoleculesApplication 63551886Pending
- Probe Blockers For Enrichment Of Target Nucleic Acid SequencesApplication 63618152Pending
- Gastrointestinal Tests For High Risk PopulationsApplication 63618007Pending
- Methods For Enriching For Methylated Nucleic Acid MoleculesApplication 63663921Pending
- Tiered Testing For High Risk PopulationsApplication 63685159Pending
- Methods For Enriching For Methylated Nucleic Acid MoleculesApplication 63708356Pending
- Methods For Enriching For Methylated Nucleic Acid MoleculesApplication 63708358Pending
- Methods For Enriching For Methylated Nucleic Acid MoleculesApplication 63720536Pending
- Targeted Rare Allele Crispr EnrichmentApplication 18131628Pending
- Tiered Testing For High Risk PopulationsApplication PCTUS2025010257Pending
- Probe Blockers For Enrichment Of Target Nucleic Acid SequencesApplication PCTUS2025010284Pending
- Prioritization Of Healthcare Resources In Cancer CareApplication PCTUS2026017085Pending
- Prioritization Of Healthcare Resources In Cancer CareApplication 63910448Pending
- Prioritization Of Healthcare Resources In Cancer CareApplication 63902807Pending
- Multi-analyte Analysis for Colorectal Cancer Risk StratificationApplication 63853262Pending
- Prioritization Of Healthcare Resources In Cancer CareApplication 63852392Pending
- Multianalyte Cancer DetectionApplication 63775072Pending
- Multi-analyte Cancer DetectionApplication 63765222Pending
- Methods For Depleting Unmethylated Nucleic Acid MoleculesApplication PCTUS2025015024Pending
- Methods And Compositions For Detecting Methylation PatternsApplication 63766851Pending
- Methods For Enriching For Methylated Nucleic Acid MoleculesApplication PCTUS2025035273Pending
- Methods For Enriching For Methylated Nucleic Acid MoleculesApplication PCTUS2025051128Pending
- Methods For Enriching For Methylated Nucleic Acid MoleculesApplication PCTUS2025055576Pending
Related companies, and why
- LISA HEALTH INC.Similar federal contract value in Medtech · null in contracts
- CONTROLPOINT INC.Similar federal contract value in Medtech · null in contracts
- On Target Laboratories, Inc.Similar federal contract value in Medtech · null in contracts
- WAVELY DIAGNOSTICS INCSimilar federal contract value in Medtech · null in contracts
- LARIAT BIOSCIENCES, INC.Similar federal contract value in Medtech · null in contracts
- APTUS BIOSCIENCES LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .